Louise Rodino-Klapac - Jun 21, 2024 Form 4 Insider Report for Sarepta Therapeutics, Inc. (SRPT)

Role
Head of R&D, CSO
Signature
/s/ Ryan Brown as Attorney-in-Fact for Louise Rodino-Klapac
Stock symbol
SRPT
Transactions as of
Jun 21, 2024
Transactions value $
-$359,244
Form type
4
Date filed
6/25/2024, 08:00 PM
Previous filing
Mar 11, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SRPT Common Stock Options Exercise +6.25K +9.18% 74.3K Jun 21, 2024 Direct F1
transaction SRPT Common Stock Tax liability -$359K -2.18K -2.94% $164.64 72.1K Jun 24, 2024 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SRPT Performance Stock Units Award $0 +5.5K $0.00 5.5K Jun 21, 2024 Common Stock 5.5K Direct F3
transaction SRPT Performance Stock Units Award $0 +6.25K $0.00 6.25K Jun 21, 2024 Common Stock 6.25K Direct F1
transaction SRPT Performance Stock Units Options Exercise $0 -6.25K -100% $0.00* 0 Jun 21, 2024 Common Stock 6.25K Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares earned and vested under a performance stock unit ("PSU") award granted to the Reporting Person on March 1, 2024. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU. The PSUs vested immediately upon the Compensation Committee's determination of the Company's achievement of one of the prescribed milestones under the terms of the PSU.
F2 Shares were sold by the Company to satisfy tax withholding obligations related to vesting of PSUs granted on March 1, 2024.
F3 Represents the number of shares earned under a PSU award granted to the Reporting Person on March 7, 2022. The number of shares earned is based on the Compensation Committee's determination of the Company's achievement of prescribed milestones under the terms of the PSU award. The earned PSUs will vest on March 7, 2025, subject to the Reporting Person continuing to provide service to the Company through such vesting date.